NORTHERN TRUST CORP - CHECKPOINT THERAPEUTICS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$120,000
+6.2%
115,152
+4.3%
0.00%
Q2 2022$113,000
-42.1%
110,3840.0%0.00%
Q1 2022$195,000
-45.5%
110,384
-4.0%
0.00%
Q4 2021$358,000
-5.8%
114,9500.0%0.00%
Q3 2021$380,000
+8.6%
114,950
-3.1%
0.00%
Q2 2021$350,000
-78.9%
118,644
-77.5%
0.00%
Q1 2021$1,656,000
+11.1%
527,523
-6.2%
0.00%
Q4 2020$1,491,000
+9.6%
562,491
+10.9%
0.00%
Q3 2020$1,360,000
+34.7%
507,161
-0.6%
0.00%
Q2 2020$1,010,000
+56.8%
509,981
+19.5%
0.00%
Q1 2020$644,000
+33.6%
426,786
+52.3%
0.00%
Q4 2019$482,000
-25.4%
280,253
+8.0%
0.00%
Q3 2019$646,000
+249.2%
259,598
+325.2%
0.00%
Q2 2019$185,000
+55.5%
61,048
+46.5%
0.00%
Q1 2019$119,000
+56.6%
41,6740.0%0.00%
Q4 2018$76,000
-49.0%
41,6740.0%0.00%
Q3 2018$149,00041,6740.00%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 1,167,332$3,852,0002.54%
Spotlight Asset Group, Inc. 661,597$2,183,0001.09%
PVG ASSET MANAGEMENT CORP 89,127$294,119,0000.88%
EMFO, LLC 243,450$803,0000.71%
Telemetry Investments, L.L.C. 70,000$231,0000.31%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,872$435,0000.22%
ASSET MANAGEMENT CORP /IL/ /ADV 85,750$283,0000.14%
Tatro Capital, LLC 18,357$61,0000.05%
EXANE DERIVATIVES 48,230$159,153,0000.04%
Occidental Asset Management, LLC 26,400$87,0000.02%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders